FDA approved Cassipa (buprenorphine and naloxone) sublingual film (applied under the tongue) for the maintenance treatment of opioid dependence.
Read more: FDA approves new dosage strength of buprenorphine and naloxone sublingual film as maintenance treatment for opioid dependence